These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3116665)

  • 1. [The so-called refractory anemias].
    Frick P
    Schweiz Med Wochenschr; 1987 Sep; 117(36):1347-50. PubMed ID: 3116665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
    Rodríguez JN; Prados D; Martino ML; Muñiz R
    Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
    Musto P; Falcone A; Carotenuto M; Catalano L; Cennamo A; Rotoli B
    Blood; 1994 Sep; 84(5):1687-8. PubMed ID: 7520783
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin.
    Orbach H; Ben-Yehuda A; Ben-Yehuda D; Manor D; Rubinow A; Naparstek Y
    J Rheumatol; 1995 Nov; 22(11):2166-9. PubMed ID: 8596164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant erythropoietin for refractory anemia with ring sideroblasts.
    Musto P; Catalano L; Andriani A; Bodenizza C; Cascavilla N; Di Renzo N; Melillo L; Cicoira L; Carotenuto M; Rotoli B
    Haematologica; 1992; 77(2):185-6. PubMed ID: 1398306
    [No Abstract]   [Full Text] [Related]  

  • 6. [The concept of and countermeasures in refractory anemia].
    Yoshida Y
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):593-7. PubMed ID: 2199586
    [No Abstract]   [Full Text] [Related]  

  • 7. Refractory anemia in the elderly.
    Gardner FH
    Adv Intern Med; 1987; 32():155-75. PubMed ID: 3548248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged course of pure red cell aplasia after erythropoietin therapy.
    Nigg L; Schanz U; Ambühl PM; Fehr J; Bachli EB
    Eur J Haematol; 2004 Nov; 73(5):376-9. PubMed ID: 15458518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
    Rossert J; Casadevall N
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].
    Grzegorzewska AE; Sucharzewska-Tomczak M
    Pol Merkur Lekarski; 2004 Oct; 17(100):407-9. PubMed ID: 15690716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aplastic anemia and pure red cell aplasia: diagnosis and treatment].
    Sawada K
    Rinsho Ketsueki; 2006 Mar; 47(3):176-89. PubMed ID: 16629482
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin--advent of a new treatment.
    Winearls C
    Practitioner; 1987 Oct; 231(1436):1269-73. PubMed ID: 3333088
    [No Abstract]   [Full Text] [Related]  

  • 14. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin.
    Martelli M; Ponchio L; Beguin Y; Meloni G; Mandelli F; Cazzola M
    Haematologica; 1994; 79(5):456-9. PubMed ID: 7843633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.
    Ljung T; Bäck R; Hellström-Lindberg E
    Haematologica; 2004 Dec; 89(12):1446-53. PubMed ID: 15590394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pure red cell aplasia after allogeneic peripheral blood stem cell transplantation: a case report and literature review].
    Li C; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):359-61. PubMed ID: 11721433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
    Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
    Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of plasmapheresis in the treatment of Blackfan-Diamond erythroid aplasia. Presentation of a case].
    Colombino G; Bonzano L
    Minerva Med; 1987 Nov; 78(21):1571-3. PubMed ID: 3120056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to recombinant human erythropoietin causing pure red cell aplasia.
    Prabhakar SS; Muhlfelder T
    Clin Nephrol; 1997 May; 47(5):331-5. PubMed ID: 9181281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of differentiation syndrome in an elderly patient with acute promyelocytic leukemia who subsequently developed refractory anemia with ring sideroblasts.
    Denu RA; Henrich Lobo R; Mattison RJ
    Leuk Lymphoma; 2016 Dec; 57(12):2905-2907. PubMed ID: 27073113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.